MyFinsight
Home
Blog
About
Back
Cash Flow
ACTUATE THERAPEUTICS, INC. (ACTU)
ACTUATE THERAPEUTICS, INC. (ACTU)
source: myfinsight.com
Proceeds from sale of
shares under...
$731,589
(-66.18%↓ Y/Y)
Net cash provided by
financing activities
$696,960
(-89.51%↓ Y/Y)
Canceled cashflow
$34,629
Net change in cash
and cash...
-$3,708,163
(-72.56%↓ Y/Y)
Canceled cashflow
$696,960
Stock-based compensation
expense
$1,340,769
(-50.42%↓ Y/Y)
Prepaid assets and other
current assets
-$63,344
(82.90%↑ Y/Y)
Interest accrued on
license payable
$5,063
(-50.00%↓ Y/Y)
Deferred offering costs
$34,629
(-80.24%↓ Y/Y)
Net cash used in
operating activities
-$4,405,123
(49.90%↑ Y/Y)
Canceled cashflow
$1,409,176
Net loss
-$4,866,635
(60.33%↑ Y/Y)
Accrued compensation
-$499,072
(-199.88%↓ Y/Y)
Other accrued
expenses
-$297,990
(77.95%↑ Y/Y)
Accounts payable
-$150,602
(-113.33%↓ Y/Y)
Back